The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.
Excerpt from:
FDA Approves Effient to Reduce the Risk of Heart Attack in Angioplasty Patients
The U.S. Food and Drug Administration today announced a regulation expected to prevent each year 79,000 cases of foodborne illness and 30 deaths caused by consumption of eggs contaminated with the bacterium Salmonella enteritidis.
View post:
FDA: New Public Health Regulation to Improve Egg Safety and Reduce Salmonella Illnesses
The U.S.
Go here to read the rest:
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene
The U.S. Food and Drug Administration is taking steps to improve contact lens safety by reminding consumers of the importance of following proper cleaning and storing procedures.
Read the original here:
FDA Taking Steps to Improve Contact Lens Safety
The U.S. Food and Drug Administration is taking steps to improve contact lens safety by reminding consumers of the importance of following proper cleaning and storing procedures
Read the original post:
FDA Taking Steps to Improve Contact Lens Safety
DOMEGA INTERNATIONAL LTD., INC., of 1916 W 13TH Street, Brooklyn, NY 11223 is recalling FMD BRAND SPICED BEAN because it contains undeclared sulfites. People who have severe sensitivity to sulfites run the risk of serious or life-threatening reactions if they consume this product.
Continued here:
Domega International Co Ltd, Issues an Alert on Undeclared Sulfites in FMD Brand Spiced Bean
The FDA today announced that manufacturers of 25 types of medical devices marketed prior to 1976 must submit safety and effectiveness information to the agency so that it may evaluate the risk level for each device type. Devices found by the FDA to be of high risk to consumers will be required to undergo the agency’s most stringent premarket review process.
Read this article:
FDA to Review Medical Devices Marketed Prior to 1976